Search research articles
Contact Us
Filters
Showing results (61-70 of 129) with videos related to
Page
of 13
Sort By:
Journal of Translational Medicine
|
November 30, 2011
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid, Henrik Schmidt, Aviram Nissan, et al.
Scientific Reports
|
November 27, 2022
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
Maria Colomba Comes, Livia Fucci, Fabio Mele, et al.
Dermatology (Basel, Switzerland)
|
June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma
Vanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.
Frontiers in Cell and Developmental Biology
|
June 29, 2023
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: <i>in vitro</i> and <i>ex vivo</i> evaluations in patient-derived organoids
Roberta Di Fonte, Sabino Strippoli, Marianna Garofoli, et al.
BMC Cancer
|
March 1, 2006
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]
Vanna Chiarion-Sileni, Paola Del Bianco, Antonella Romanini, et al.
Frontiers in Molecular Biosciences
|
March 22, 2021
The Genetic Germline Background of Single and Multiple Primary Melanomas
Simona De Summa, Antonia Lasorella, Sabino Strippoli, et al.
Frontiers in Oncology
|
October 4, 2021
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp
Davide Quaresmini, Alessandra Di Lauro, Livia Fucci, et al.
Cells
|
March 6, 2021
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma
Sabino Strippoli, Annarita Fanizzi, Antonio Negri, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 5, 2025
Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients
Amalia Azzariti, Simona De Summa, Tommaso M Marvulli, et al.
Journal of Translational Medicine
|
January 13, 2019
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α
Immacolata Maida, Paola Zanna, Stefania Guida, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 129) with videos related to
Sort By:
Page
of 13
Journal of Translational Medicine
|
November 30, 2011
A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
Omid Hamid, Henrik Schmidt, Aviram Nissan, et al.
Scientific Reports
|
November 27, 2022
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
Maria Colomba Comes, Livia Fucci, Fabio Mele, et al.
Dermatology (Basel, Switzerland)
|
June 6, 2013
Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma
Vanna Chiarion-Sileni, Michele Guida, Antonella Romanini, et al.
Frontiers in Cell and Developmental Biology
|
June 29, 2023
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: <i>in vitro</i> and <i>ex vivo</i> evaluations in patient-derived organoids
Roberta Di Fonte, Sabino Strippoli, Marianna Garofoli, et al.
BMC Cancer
|
March 1, 2006
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]
Vanna Chiarion-Sileni, Paola Del Bianco, Antonella Romanini, et al.
Frontiers in Molecular Biosciences
|
March 22, 2021
The Genetic Germline Background of Single and Multiple Primary Melanomas
Simona De Summa, Antonia Lasorella, Sabino Strippoli, et al.
Frontiers in Oncology
|
October 4, 2021
Electrochemotherapy as a Trigger to Overcome Primary Resistance to Anti-PD-1 Treatment: A Case Report of Melanoma of the Scalp
Davide Quaresmini, Alessandra Di Lauro, Livia Fucci, et al.
Cells
|
March 6, 2021
Examining the Relationship between Circulating CD4- CD8- Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy-Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma
Sabino Strippoli, Annarita Fanizzi, Antonio Negri, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
February 5, 2025
Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients
Amalia Azzariti, Simona De Summa, Tommaso M Marvulli, et al.
Journal of Translational Medicine
|
January 13, 2019
Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α
Immacolata Maida, Paola Zanna, Stefania Guida, et al.
Page
of 13